日本-话题@MedSci

#日本#

594篇内容 | 8360人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294475, encodeId=dbab12944e5e0, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本开发出便携式血液净化装置可抢救肾病患者, objectType=article, longId=168753, objectId=4093168e530d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4093168e530d, replyNumber=0, likeNumber=82, createdTime=2019-06-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4093168e530d, moduleTitle=日本开发出便携式血液净化装置可抢救肾病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4093168e530d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294474, encodeId=8c6212944e4c1, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本研发出用一滴血检测多种癌症的技术, objectType=article, longId=168232, objectId=d8a91682320e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a91682320e, replyNumber=0, likeNumber=82, createdTime=2019-06-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a91682320e, moduleTitle=日本研发出用一滴血检测多种癌症的技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a91682320e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294473, encodeId=201b12944e372, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本网红眼药水被他国禁售专家：对心血管造成压力, objectType=article, longId=167958, objectId=652816e958a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=652816e958a8, replyNumber=0, likeNumber=67, createdTime=2019-06-11, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=652816e958a8, moduleTitle=日本网红眼药水被他国禁售专家：对心血管造成压力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=652816e958a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294472, encodeId=a10712944e254, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本团队研发智能材料可用于抗癌和透析, objectType=article, longId=167301, objectId=4cc316e30144, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cc316e30144, replyNumber=0, likeNumber=72, createdTime=2019-06-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cc316e30144, moduleTitle=日本团队研发智能材料可用于抗癌和透析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cc316e30144)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294471, encodeId=29ec12944e1d8, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=中医是中国国粹却被韩国申“遗”成功被日本抢走210个古方专利, objectType=article, longId=167146, objectId=612316e1461a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=612316e1461a, replyNumber=0, likeNumber=87, createdTime=2019-05-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=612316e1461a, moduleTitle=中医是中国国粹却被韩国申“遗”成功被日本抢走210个古方专利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=612316e1461a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294470, encodeId=a46d12944e0de, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本幽门螺杆菌感染管理指南（修订版）, objectType=article, longId=166924, objectId=7380166924fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7380166924fe, replyNumber=0, likeNumber=18, createdTime=2019-05-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7380166924fe, moduleTitle=日本幽门螺杆菌感染管理指南（修订版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7380166924fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294469, encodeId=f5ed129446971, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=“医二代”变多，日本网红眼药水被召回，默沙东K药单药疗法三期失败, objectType=article, longId=166910, objectId=06a21669103b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06a21669103b, replyNumber=0, likeNumber=77, createdTime=2019-05-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06a21669103b, moduleTitle=“医二代”变多，日本网红眼药水被召回，默沙东K药单药疗法三期失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06a21669103b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294468, encodeId=32731294468ca, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本乳腺癌新药VERZENIO副作用疑致3人死亡, objectType=article, longId=166595, objectId=a49c16659582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a49c16659582, replyNumber=0, likeNumber=43, createdTime=2019-05-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a49c16659582, moduleTitle=日本乳腺癌新药VERZENIO副作用疑致3人死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a49c16659582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294467, encodeId=56d0129446e3c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本卫生部发出警告，乳腺癌药物Verzenio可能对肺部产生严重的副作用, objectType=article, longId=166313, objectId=6efb166313f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6efb166313f3, replyNumber=0, likeNumber=98, createdTime=2019-05-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6efb166313f3, moduleTitle=日本卫生部发出警告，乳腺癌药物Verzenio可能对肺部产生严重的副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6efb166313f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294466, encodeId=b413129446622, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=PNAS：破解PD-1抗体促进癌症超进展之谜！日本科学家发现PD-1抗体可激活调节T细胞，导致癌症超进展, objectType=article, longId=165899, objectId=551416589938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=551416589938, replyNumber=0, likeNumber=61, createdTime=2019-05-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=551416589938, moduleTitle=PNAS：破解PD-1抗体促进癌症超进展之谜！日本科学家发现PD-1抗体可激活调节T细胞，导致癌症超进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=551416589938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294465, encodeId=1dcf129446505, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本成胃癌防治很大赢家，中国能迎头赶上吗？, objectType=article, longId=165332, objectId=639216533256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639216533256, replyNumber=0, likeNumber=63, createdTime=2019-05-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639216533256, moduleTitle=日本成胃癌防治很大赢家，中国能迎头赶上吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639216533256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294464, encodeId=926c12944641f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本研究确认世界iPS细胞异体移植手术安全性，但未大幅改善视力, objectType=article, longId=164640, objectId=a01816464062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a01816464062, replyNumber=0, likeNumber=51, createdTime=2019-04-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a01816464062, moduleTitle=日本研究确认世界iPS细胞异体移植手术安全性，但未大幅改善视力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a01816464062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294463, encodeId=1c9e129446367, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Daiichi Sankyo的EZH1/2双重抑制剂Valemetostat获得日本厚生劳动省SAKIGAKE指定，用于治疗复发/难治性外周T细胞淋巴瘤, objectType=article, longId=163986, objectId=5b4b163986c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b4b163986c0, replyNumber=0, likeNumber=47, createdTime=2019-04-11, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b4b163986c0, moduleTitle=Daiichi Sankyo的EZH1/2双重抑制剂Valemetostat获得日本厚生劳动省SAKIGAKE指定，用于治疗复发/难治性外周T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b4b163986c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294462, encodeId=abb41294462ee, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定, objectType=article, longId=163899, objectId=93891638993f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93891638993f, replyNumber=0, likeNumber=64, createdTime=2019-04-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93891638993f, moduleTitle=成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93891638993f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294461, encodeId=c0d412944618e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=SanBio宣布其再生细胞疗法SB623治疗创伤性脑损伤，获得日本厚生劳动省Sakigake指定, objectType=article, longId=163898, objectId=0ea91638984f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ea91638984f, replyNumber=0, likeNumber=67, createdTime=2019-04-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ea91638984f, moduleTitle=SanBio宣布其再生细胞疗法SB623治疗创伤性脑损伤，获得日本厚生劳动省Sakigake指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ea91638984f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294460, encodeId=9d121294460ba, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本的开放式创新，在手术室里开辟了新的天地, objectType=article, longId=163499, objectId=4d431634995c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d431634995c, replyNumber=0, likeNumber=76, createdTime=2019-04-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d431634995c, moduleTitle=日本的开放式创新，在手术室里开辟了新的天地, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d431634995c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294459, encodeId=af5012944598d, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=全球首批！艾伯维银屑病新药在日本上市, objectType=article, longId=163083, objectId=b22316308396, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b22316308396, replyNumber=0, likeNumber=91, createdTime=2019-03-29, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b22316308396, moduleTitle=全球首批！艾伯维银屑病新药在日本上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b22316308396)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294458, encodeId=f66a129445833, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本研发“药片式”内服体温计，可随排泄物排出体外, objectType=article, longId=162378, objectId=16d71623e823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d71623e823, replyNumber=0, likeNumber=87, createdTime=2019-03-16, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d71623e823, moduleTitle=日本研发“药片式”内服体温计，可随排泄物排出体外, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d71623e823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294457, encodeId=9f27129445ef4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=由于英国脱欧，日本盐野义制药公司Shionogi计划将总部从英国迁移到荷兰, objectType=article, longId=162221, objectId=278416222109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=278416222109, replyNumber=0, likeNumber=60, createdTime=2019-03-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=278416222109, moduleTitle=由于英国脱欧，日本盐野义制药公司Shionogi计划将总部从英国迁移到荷兰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=278416222109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294456, encodeId=9c59129445620, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=中国人口老龄化现象引海外关注日本企业嗅出商机, objectType=article, longId=162137, objectId=955416213ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=955416213ed1, replyNumber=0, likeNumber=59, createdTime=2019-03-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=955416213ed1, moduleTitle=中国人口老龄化现象引海外关注日本企业嗅出商机, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=955416213ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

日本

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#日本#

日本开发出便携式血液净化装置可抢救肾病患者

2019-06-20

chentianping (审核中...)

前往app查看评论内容

#日本#

日本研发出用一滴血检测多种癌症的技术

2019-06-14

chentianping (审核中...)

前往app查看评论内容

#日本#

日本网红眼药水被他国禁售专家：对心血管造成压力

2019-06-11

chentianping (审核中...)

前往app查看评论内容

#日本#

日本团队研发智能材料可用于抗癌和透析

2019-06-02

chentianping (审核中...)

前往app查看评论内容

#日本#

中医是中国国粹却被韩国申“遗”成功被日本抢走210个古方专利

2019-05-31

chentianping (审核中...)

前往app查看评论内容

#日本#

日本幽门螺杆菌感染管理指南（修订版）

2019-05-28

chentianping (审核中...)

前往app查看评论内容

#日本#

“医二代”变多，日本网红眼药水被召回，默沙东K药单药疗法三期失败

2019-05-28

chentianping (审核中...)

前往app查看评论内容

#日本#

日本乳腺癌新药VERZENIO副作用疑致3人死亡

2019-05-23

chentianping (审核中...)

前往app查看评论内容

#日本#

日本卫生部发出警告，乳腺癌药物Verzenio可能对肺部产生严重的副作用

2019-05-20

chentianping (审核中...)

前往app查看评论内容

#日本#

PNAS：破解PD-1抗体促进癌症超进展之谜！日本科学家发现PD-1抗体可激活调节T细胞，导致癌症超进展

2019-05-13

chentianping (审核中...)

前往app查看评论内容

#日本#

日本成胃癌防治很大赢家，中国能迎头赶上吗？

2019-05-05

chentianping (审核中...)

前往app查看评论内容

#日本#

日本研究确认世界iPS细胞异体移植手术安全性，但未大幅改善视力

2019-04-22

chentianping (审核中...)

前往app查看评论内容

#日本#

Daiichi Sankyo的EZH1/2双重抑制剂Valemetostat获得日本厚生劳动省SAKIGAKE指定，用于治疗复发/难治性外周T细胞淋巴瘤

2019-04-11

chentianping (审核中...)

前往app查看评论内容

#日本#

成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定

2019-04-10

chentianping (审核中...)

前往app查看评论内容

#日本#

SanBio宣布其再生细胞疗法SB623治疗创伤性脑损伤，获得日本厚生劳动省Sakigake指定

2019-04-10

chentianping (审核中...)

前往app查看评论内容

#日本#

日本的开放式创新，在手术室里开辟了新的天地

2019-04-04

chentianping (审核中...)

前往app查看评论内容

#日本#

全球首批！艾伯维银屑病新药在日本上市

2019-03-29

chentianping (审核中...)

前往app查看评论内容

#日本#

日本研发“药片式”内服体温计，可随排泄物排出体外

2019-03-16

chentianping (审核中...)

前往app查看评论内容

#日本#

由于英国脱欧，日本盐野义制药公司Shionogi计划将总部从英国迁移到荷兰

2019-03-14

chentianping (审核中...)

前往app查看评论内容

#日本#

中国人口老龄化现象引海外关注日本企业嗅出商机

2019-03-13

科室
- - 订阅+
  - 更多科室
工具
服务